NCT00009971View on ClinicalTrials.gov

Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 30, 2000

Primary Completion Date

September 30, 2005

Conditions
Lung Cancer
Interventions
DRUG

fenretinide

Trial Locations (2)

48109-0752

University of Michigan Comprehensive Cancer Center, Ann Arbor

48201-1379

Barbara Ann Karmanos Cancer Institute, Detroit

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00009971 - Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter